Gentile Kimberly 4
4 · Biohaven Ltd. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Biohaven Ltd.BHVN
Gentile Kimberly
SVP, Clinical Operations
Transactions
- Award
Stock Options (Right to buy)
2024-01-02+96,250→ 96,250 totalExercise: $41.93Exp: 2034-01-02→ Common Shares (96,250 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in four equal installments on January 2, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service with the Issuer at each vesting date.